Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-13-000134

Options or other derivatives

  • CFO & EVP Business Development acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDOP CHRISTOPHER J · CFO & EVP Business Development

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-07-24 Grant or award : show line 1 in the form Performance Shares +25,000 $0.00 2017-12-31 25,000 25,000 D
Loading xslF345X03/edgardoc.xml…